TPX2 enhances the transcription factor activation of PXR and enhances the resistance of hepatocellular carcinoma cells to antitumor drugs
Abstract The pregnane X receptor (PXR) is an important regulator of hepatocellular carcinoma cellular resistance to antitumor drugs. Activation of PXR was modulated by the co-regulators. The target protein for the Xenopus plus end-directed kinesin-like protein (Xklp2) known as TPX2 that was previous...
Main Authors: | Hongbo Wang, Fang Chu, Xiao-feng Zhang, Peng Zhang, Li-xin Li, Yun-long Zhuang, Xiao-feng Niu, Xi He, Zhi-jie Li, Ying Bai, Da Mao, Zhen-wen Liu, Da-li Zhang, Bo-an Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2023-01-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-022-05537-7 |
Similar Items
-
MTBP enhances the activation of transcription factor ETS-1 and promotes the proliferation of hepatocellular carcinoma cells
by: Hongbo Wang, et al.
Published: (2022-08-01) -
A Single Nucleotide Mixture Enhances the Antitumor Activity of Molecular-Targeted Drugs Against Hepatocellular Carcinoma
by: Da Mao, et al.
Published: (2022-06-01) -
Effect of TPX2 expression on prognosis of pancreatic carcinoma
by: SU Jingyu, ZHANG Zhenxi, DU Wenjing
Published: (2023-06-01) -
Eg5 and TPX2 in cohesion fatigue
by: Yeap, Szu Ling
Published: (2015) -
Structural insight into the macrocyclic inhibitor TPX-0022 of c-Met and c-Src
by: Lingzhi Qu, et al.
Published: (2023-01-01)